HWAM
VRTX icon

Hennion & Walsh Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Sell
3,983
-46
-1% -$20.4K 0.06% 382
2026
Q1 		$1.8M Sell
4,029
-783
-16% -$365K 0.06% 371
2025
Q4 		$2.18M Sell
4,812
-1,192
-20% -$514K 0.08% 335
2025
Q3 		$2.35M Sell
6,004
-752
-11% -$314K 0.09% 305
2025
Q2 		$3.01M Sell
6,756
-39
-0.6% -$18K 0.12% 221
2025
Q1 		$3.29M Sell
6,795
-1,331
-16% -$620K 0.15% 178
2024
Q4 		$3.27M Buy
8,126
+554
+7% +$257K 0.15% 177
2024
Q3 		$3.52M Sell
7,572
-17
-0.2% -$8.17K 0.16% 157
2024
Q2 		$3.56M Buy
7,589
+583
+8% +$253K 0.18% 135
2024
Q1 		$2.93M Buy
7,006
+515
+8% +$218K 0.16% 175
2023
Q4 		$2.64M Buy
6,491
+955
+17% +$353K 0.15% 196
2023
Q3 		$1.93M Buy
5,536
+1,412
+34% +$494K 0.12% 223
2023
Q2 		$1.45M Buy
4,124
+827
+25% +$279K 0.09% 287
2023
Q1 		$1.04M Buy
3,297
+1,472
+81% +$441K 0.06% 348
2022
Q4 		$527K Buy
1,825
+262
+17% +$79.8K 0.03% 488
2022
Q3 		$453K Buy
+1,563
New +$450K 0.03% 500

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Hennion & Walsh Asset Management's VRTX Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, selling an estimated $20.4K and leaving 3,983 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #382.

Hennion & Walsh Asset Management first reported a position in VRTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.56M in Q2 2024. 368 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hennion & Walsh Asset Management held 3,983 shares of Vertex Pharmaceuticals worth $1.98M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 46 Vertex Pharmaceuticals shares in Q2 2026, an estimated $20.4K.
  • Vertex Pharmaceuticals made up 0.06% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #382 holding.
  • Hennion & Walsh Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Hennion & Walsh Asset Management's Vertex Pharmaceuticals position peaked at $3.56M in Q2 2024.
  • 368 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.